Edwards Lifesciences (EW) Invested Capital (2009 - 2026)

Edwards Lifesciences' Invested Capital history runs 18 years deep, the most recent figure standing at $10.3 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 1.33% year-over-year to $10.3 billion; the TTM figure through Mar 2026 stood at $10.3 billion (up 1.33% YoY), while the FY2025 annual figure was $10.9 billion, up 2.58% from the prior year.
• Invested Capital was $10.3 billion for Q1 2026 at Edwards Lifesciences, down from $10.9 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $10.9 billion in Q4 2025 to a low of $5.8 billion in Q1 2022.
• Historically, Invested Capital has averaged $8.1 billion across 5 years, with a median of $7.3 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Invested Capital declined 0.44% in 2022, then soared 45.71% in 2024.
• A 5-year view of Invested Capital shows it stood at $6.4 billion in 2022, then rose by 14.27% to $7.3 billion in 2023, then surged by 45.71% to $10.7 billion in 2024, then grew by 2.58% to $10.9 billion in 2025, then dropped by 5.56% to $10.3 billion in 2026.
• The last three Invested Capital figures came in at $10.3 billion (Q1 2026), $10.9 billion (Q4 2025), and $10.2 billion (Q3 2025), per Business Quant data.